SCHULMAN AMY W 4

What Happened
Amy W. Schulman, a member of the Elevance Health, Inc. (ELV) board of directors, was granted 563 deferred stock units (DSUs) on 2026-05-13. The Form 4 reports the acquisition price as $0.00 (transaction code A for Award/Grant); the filing lists the reported transaction value as $0. These DSUs are compensation, not an open-market purchase or sale.

Key Details

• Transaction date: 2026-05-13; Form 4 filed: 2026-05-15 (filed within the typical 2-business-day Form 4 deadline).
• Transaction type: Award/Grant (code A); amount: 563 deferred stock units; price reported: $0.00; reported dollar value: $0.
• Shares owned after the transaction: not disclosed in the filing.
• Footnotes: F1 — DSUs accrued under the Company’s Board of Directors Compensation Program. F2 — DSUs will be payable in Company common stock upon the earlier of (a) five years from grant or (b) the date the reporting person leaves the board, unless a later payout date was elected.
• No 10b5-1 plan, tax-withholding, or cashless-sale details are reported for this transaction.

Context
Deferred stock units are a form of director compensation that convert to company shares at a future date (vesting or departure) and are not immediately tradable. This award is routine director compensation and should not be interpreted as an immediate buy or sell signal; it aligns part of the director’s pay with future equity value rather than indicating near-term insider sentiment.